AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Carvedka 3.125mg Tablet

Prescription Icon
Prescription Required

Marketer

Arkamed Pharmaa

Salt Composition

Carvedilol (3.125mg)

Overview Carvedka 3.125mg Tablet

Lanoxin 3.125mg tablets effectively manage hypertension, angina pectoris, and congestive heart failure. Its mechanism involves vasodilation, improving blood flow to the heart. Reduced blood pressure consequently minimizes the risk of myocardial infarction and cerebrovascular accidents. Administer Lanoxin 3.125mg tablets with food, following your physician's prescribed dosage and regimen. Consistent use is crucial, even with symptom improvement or controlled blood pressure. Discontinuing treatment necessitates prior consultation to prevent potential complications. Lifestyle modifications, including regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as directed by your doctor), enhance therapeutic outcomes. While generally well-tolerated, potential side effects such as vertigo, cephalalgia, dyspnea, and fatigue may occur. Report persistent or bothersome side effects to your doctor. Prior to initiating treatment, disclose any pre-existing cardiac or renal conditions. Pregnant or lactating women should seek medical counsel before commencing therapy.

Uses of Carvedka 3.125mg Tablet

Managing elevated blood pressure | Alleviating angina pectoris | Treating congestive heart failure

Major Benefits of Carvedka 3.125mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 3.125mg Carvedka tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Carvedka 3.125mg Tablet:

  • Decreased blood pressure
  • Headache
  • Fatigue
  • Dizziness
  • Breathlessness

How to use Carvedka 3.125mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Carvedka 3.125mg Tablet should be administered with a meal.

How Carvedka 3.125mg Tablet works:

Carvedka 3.125mg tablets combine alpha and beta-blocking properties. This dual action reduces heart rate and dilates blood vessels, improving the heart's overall pumping efficiency.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Carvedka 3.125mg Tablet and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Pregnant individuals should exercise caution when considering Carvedka 3.125mg tablets. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the risks and advantages before prescribing this medication. Medical advice is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and Carvedka 3.125mg tablets appear compatible. Available data from human studies indicate minimal infant risk associated with this medication.

DrivingDrivingUNSAFE

Taking a 3.125mg Carvedka tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely take Carvedka 3.125mg tablets without a recommended dosage change. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advised. Routine blood pressure monitoring is suggested to guide potential dosage modifications.

LiverLiverCAUTION

Patients with liver impairment should use Carvedka 3.125mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Carvedka 3.125mg tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Carvedka 3.125mg Tablet :

Should you forget to take your Carvedka 3.125mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Carvedka 3.125mg Tablet

LabelValue
Type of Compound Carbazole-based compound and a propanol derivative
Potential for Dependence None.
Type of Treatment HEART
Mechanism of Action Combined alpha and beta-adrenergic antagonist

FAQs on Carvedka 3.125mg Tablet

Consistent use of Carvedka 3.125mg tablets, as prescribed by your physician, is essential. Abrupt cessation may result in chest pain or myocardial infarction. If discontinuation is necessary, your doctor will gradually reduce your dosage to minimize risk.
Carvedka 3.125mg tablets can induce fatigue and dizziness, particularly at treatment initiation or following dose escalation. Driving or operating machinery should be avoided if these side effects are present.
Weight increase is a frequent, though not universal, side effect of Carvedka 3.125mg Tablet. Patients using Carvedka 3.125mg Tablet for heart failure should report any weight gain or shortness of breath to their physician; these could indicate fluid buildup.
In some instances, administering Carvedka 3.125mg tablets to patients with heart failure might negatively impact kidney function. The risk of kidney failure is heightened in individuals with low blood pressure (systolic below 100 mm Hg), arterial stiffening, pre-existing heart disease, or compromised kidney function. Close monitoring is crucial for these patients while taking Carvedka 3.125mg tablets. Kidney function typically recovers once Carvedka 3.125mg tablet use ceases.
Diabetic individuals may use Carvedka 3.125mg tablets, contingent upon consistent blood glucose monitoring. Studies indicate this dosage doesn't impact blood glucose in well-managed type 2 diabetes with mild to moderate hypertension. Nevertheless, beta-blockers, the class to which Carvedka belongs, can mask hypoglycemic symptoms like tachycardia, potentially delaying treatment. Furthermore, Carvedka 3.125mg tablets might exacerbate hyperglycemia in diabetic patients with heart failure. Therefore, close blood glucose monitoring is crucial when starting, altering, or stopping Carvedka 3.125mg tablet treatment. Report any blood glucose fluctuations to your physician during therapy.
To minimize the risk of orthostatic hypotension, a condition causing dizziness or fainting upon standing due to low blood pressure, it's advisable to ingest Carvedka 3.125mg Tablet with a meal. Food consumption slows the medication's absorption rate.
Taking Carvedka 3.125mg tablets can lead to severe adverse reactions including dizziness, breathlessness, increased weight, and edema in the extremities (arms, hands, feet, ankles, or lower legs). Other potential side effects are chest discomfort, bradycardia or arrhythmia, skin eruptions (rash, hives, itching), and respiratory or swallowing difficulties. Seek immediate medical attention should any of these occur.
Exceeding the prescribed dosage of Carvedka 3.125mg Tablets can result in bradycardia, vertigo, syncope, respiratory distress, emesis, and potential loss of consciousness or convulsions. Consult your physician and obtain prompt medical attention at the nearest healthcare facility.
The use of Carvedka 3.125mg Tablets is contraindicated in patients with severe heart failure requiring intensive care unit admission or treatment with circulatory support medications (inotropes). Furthermore, Carvedka 3.125mg Tablets should not be administered to individuals with a history of asthma or respiratory difficulties, bradycardia or arrhythmia, hepatic impairment, or known allergy to Carvedka 3.125mg Tablets.
Carvedka 3.125mg Tablet
27
MRP 33
18% off